Femtomolar concentrations of dextromethorphan protect mesencephalic dopaminergic neurons from inflammatory damage
暂无分享,去创建一个
Tongguang Wang | M. Block | Sung-Jen Wei | Jau-Shyong Hong | Guorong Li | Tongguang Wang | Jau-Shyong Hong | Nian-Sheng Tzeng | Sung-Jen Wei | Michelle L Block | Gang Cui | Nian-Ssheng Tzeng | Guorong Li | G. Cui
[1] I. Gozes,et al. NAP, a Femtomolar-Acting Peptide, Protects the Brain Against Ischemic Injury by Reducing Apoptotic Death , 2002, Stroke.
[2] P. Rameshwar,et al. Stimulation of IL-2 production in murine lymphocytes by substance P and related tachykinins. , 1993, Journal of immunology.
[3] B. Liu,et al. Dextromethorphan Protects Dopaminergic Neurons against Inflammation-Mediated Degeneration through Inhibition of Microglial Activation , 2003, Journal of Pharmacology and Experimental Therapeutics.
[4] G. Steinberg,et al. Dextromethorphan reduces neocortical ischemic neuronal damage in vivo , 1988, Brain Research.
[5] D. Dickson,et al. Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer's disease , 1993, Glia.
[6] B. Liu,et al. Primary rat mesencephalic neuron-glia, neuron-enriched, microglia-enriched, and astroglia-enriched cultures. , 2003, Methods in molecular medicine.
[7] D. Choi,et al. Morphinans attenuate cortical neuronal injury induced by glucose deprivation in vitro , 1988, Brain Research.
[8] Bin Liu,et al. NADPH Oxidase Mediates Lipopolysaccharide-induced Neurotoxicity and Proinflammatory Gene Expression in Activated Microglia* , 2004, Journal of Biological Chemistry.
[9] Bin Liu,et al. Microglia enhance β‐amyloid peptide‐induced toxicity in cortical and mesencephalic neurons by producing reactive oxygen species , 2002 .
[10] Bin Liu,et al. Microglial activation‐mediated delayed and progressive degeneration of rat nigral dopaminergic neurons: relevance to Parkinson's disease , 2002, Journal of neurochemistry.
[11] Bin Liu,et al. Microglia enhance beta-amyloid peptide-induced toxicity in cortical and mesencephalic neurons by producing reactive oxygen species. , 2002, Journal of neurochemistry.
[12] L. Sazanov,et al. Inhibition of the respiratory burst in mouse macrophages by ultra‐low doses of an opioid peptide is consistent with a possible adaptation mechanism , 1994, FEBS letters.
[13] Teruo Hayashi,et al. Antiapoptotic and cytotoxic properties of delta opioid peptide [D‐Ala2,D‐Leu5]enkephalin in PC12 cells , 2002, Synapse.
[14] P. Mcgeer,et al. Reactive microglia are positive for HLA‐DR in the substantia nigra of Parkinson's and Alzheimer's disease brains , 1988, Neurology.
[15] D. Shibata,et al. Dextromethorphan protects against cerebral injury following transient focal ischemia in rabbits. , 1988, Stroke.
[16] S. Tsunawaki,et al. Mutation at Histidine 338 of gp91 phox Depletes FAD and Affects Expression of Cytochrome b 558 of the Human NADPH Oxidase* , 1998, The Journal of Biological Chemistry.
[17] X. C. Lu,et al. Dextromethorphan protects against cerebral injury following transient, but not permanent, focal ischemia in rats. , 1997, Life sciences.
[18] Bin Liu,et al. Reduction by naloxone of lipopolysaccharide-induced neurotoxicity in mouse cortical neuron–glia co-cultures , 2000, Neuroscience.
[19] D. Prince,et al. Dextromethorphan protects against cerebral infarction in a rat model of hypoxia-ischemia , 1988, Neuroscience Letters.
[20] K. Shen,et al. Acute thermal hyperalgesia elicited by low-dose morphine in normal mice is blocked by ultra-low-dose naltrexone, unmasking potent opioid analgesia , 2001, Brain Research.
[21] C. Ong,et al. Role of intracellular thiol depletion, mitochondrial dysfunction and reactive oxygen species in Salvia miltiorrhiza-induced apoptosis in human hepatoma HepG2 cells. , 2001, Life sciences.
[22] D. Giulian. Microglia and the immune pathology of Alzheimer disease. , 1999, American journal of human genetics.
[23] B. Liu,et al. Inhibition by Naloxone Stereoisomers of β-Amyloid Peptide (1–42)-induced Superoxide Production in Microglia and Degeneration of Cortical and Mesencephalic Neurons , 2002, Journal of Pharmacology and Experimental Therapeutics.
[24] M. Li,et al. Delta-opioid suppression of human immunodeficiency virus-1 expression in T cells (Jurkat). , 1998, Biochemical pharmacology.
[25] J. Zweier,et al. Vascular NAD(P)H oxidase is distinct from the phagocytic enzyme and modulates vascular reactivity control. , 2001, American journal of physiology. Heart and circulatory physiology.
[26] P. Mcgeer,et al. The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases , 1995, Brain Research Reviews.
[27] Y. Hosobuchi,et al. Dynorphin(1–13) improves survival in cats with focal cerebral ischaemia , 1984, Nature.
[28] S. Gatley,et al. The effects of diphenyleneiodonium on mitochondrial reactions. Relation of binding of diphenylene[125I]iodonium to mitochondria to the extent of inhibition of oxygen uptake. , 1976, The Biochemical journal.
[29] Bin Liu,et al. Role of Microglia in Inflammation-Mediated Neurodegenerative Diseases: Mechanisms and Strategies for Therapeutic Intervention , 2003, Journal of Pharmacology and Experimental Therapeutics.
[30] T. Peng,et al. Mitochondrial dysfunction in Parkinson's disease. , 1999, Biochemical Society symposium.
[31] R. Mohney,et al. Regional Difference in Susceptibility to Lipopolysaccharide-Induced Neurotoxicity in the Rat Brain: Role of Microglia , 2000, The Journal of Neuroscience.
[32] Sim Mk,et al. Endothelium-dependent response of the rabbit aorta to femtomolar concentrations of angiotensin II. , 1991 .
[33] S. Yang,et al. Femtomolar concentrations of dynorphins protect rat mesencephalic dopaminergic neurons against inflammatory damage. , 2001, The Journal of pharmacology and experimental therapeutics.
[34] Jau-Shyong Hong,et al. Synergistic neurotoxic effects of combined treatments with cytokines in murine primary mixed neuron/glia cultures , 1998, Journal of Neuroimmunology.
[35] D. Reglodi,et al. Delayed systemic administration of PACAP38 is neuroprotective in transient middle cerebral artery occlusion in the rat. , 2000, Stroke.
[36] P. Jenner,et al. Oxidative stress in Parkinson's disease and other neurodegenerative disorders. , 1996, Pathologie-biologie.
[37] X. C. Lu,et al. Neuroprotection (focal ischemia) and neurotoxicity (electroencephalographic) studies in rats with AHN649, a 3-amino analog of dextromethorphan and low-affinity N-methyl-D-aspartate antagonist. , 1999, The Journal of pharmacology and experimental therapeutics.